Sailendra Panda

Sailendra Panda

Auto-generated profile, based on publicly available information

Sailendra Panda

All India Institute of Medical Sciences, Bhubaneswar, 751019, Odisha, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2021 in VirusDisease
Verified
Journal Article
Open access
PDF file
SSSubhra Subhadra
Subhra Subhadra
JSJyotsnamayee Sabat
Jyotsnamayee Sabat
BDBhagirathi Dwibedi
Bhagirathi Dwibedi
SPSailendra Panda
Sailendra Panda
MMMadhab Charan Mandal
Madhab Charan Mandal
JTJyotirmayee Turuk
Jyotirmayee Turuk
Newly emerging or re-emerging infections are posing continuous threat to both public health system and clinical care globally. The emergence of infections especially caused by arboviruses can be linked to several mechanisms which include geographical expansion linked to human development and transportation, global warming, enhanced transmission in peridomestic area and close proximity of human habitations to domestic as well as wild animals. The co-circulation of Dengue, Chikungunya and Zika is a matter of public health priority due to the fact that they are transmitted by the same vector as well as increase in the number of reported cases of severe dengue, post-chikungunya chronic joint disease and microcephaly related to Zika virus disease. The study was designed to estimate the prevalence of these arboviral infections in Odisha. About 5198 cases presenting with common clinical symptoms of fever, arthralgia, headache, myalgia and malaise were screened during 2016–2019. A total of 42.2% patients tested positive for dengue NS1 antigen (n = 4154), 30.2% for dengue IgM (n = 2161) and 14.3% for chikungunya IgM (n = 1816). A total of 1684 samples were subjected to Zika RT-PCR and none was tested positive. Peak in the numbers of dengue/ chikungunya cases was evident in the post-monsoon months of July – October. Circulation of all four serotypes of dengue i.e. DEN 1, 2, 3, and 4 was noticed in the state. Molecular investigation of suspected Chik cases in early phases showed circulation of Eastern Central Southern African genotype (E1:226A). There is dearth of knowledge about disease severity during arbovirus co-infections and importance of adequate management of patients at an early stage residing in risk areas. It is the first study in Odisha to study the pattern and status of these three arboviral diseases Dengue, Chikungunya and Zika. The outcome of this study will help in focusing and improvement of existing surveillance systems and vector control tools, as well as on the development of suitable antiviral agents and formulating candidate vaccine.

8 December 2022 in Cureus
Verified
Journal Article
Open access
MMMonalisa Mohanty
Monalisa Mohanty
BMBaijayantimala Mishra
Baijayantimala Mishra
ASArvind K. Singh
Arvind K. Singh
PMPrasanta Raghab Mohapatra
Prasanta Raghab Mohapatra
KGKavita Gupta
Kavita Gupta
SBSourin Bhuniya
Sourin Bhuniya
The rapidly mutating Omicron SARS-CoV-2 variant has replaced the previous dominant SARS-CoV-2 variants like alpha, and delta resulting in the amplification of coronavirus disease 2019 (COVID-19) cases. The present study was conducted to compare the clinical profile and vaccination status in patients infected with Omicron and non-Omicron SARS-CoV-2 variants. All patients who tested positive for coronavirus disease 2019 (COVID-19) during the study period (January 2022 to February 2022) were further tested for detection of SARS-CoV-2 Omicron variant by using Omisure kit (TATA MD CHECK RT-PCR, TATA MEDICAL AND DIAGNOSTICS LIMITED, Tamil Nadu, INDIA). Clinico-demographic factors and vaccination status were compared between both Omicron and non-Omicron groups. A total of 1,722 patients who tested positive for COVID-19 were included in the study, of which 656 (38.1%) were Omicron and 1,066 (61.9%) were non-Omicron SARS-CoV-2 variants. Blood group and vaccination status were the major predictors for Omicron. The proportion of male patients was 58.4% in the Omicron group and 57.9% in the non-Omicron group. Maximum cases (86.2%) belonged to >18-60 years age group, 7.3% to >60 years age group, and least to 0-18 years (6.5%). The average age of the study participants was 35.4 ± 14.5 years. Vaccinated participants had less chance of having Omicron than the unvaccinated participants (p-value - 0.003). Fever and loss of smell were found to be significantly associated with the non-Omicron SARS-CoV-2 variant. (p-value < 0.05). The present study reflects that the clinical course of the disease is milder in Omicron as compared to the non-Omicron variant. However rapid rise in cases can badly affect the healthcare system demanding good preparedness to tackle all the predicaments. Good Vaccination coverage should be of utmost priority irrespective of the variant type.

23 August 2024 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
SPSailendra Panda
Sailendra Panda
GPGayatri Patra
Gayatri Patra
BBBirendra Kumar Bindhani
Birendra Kumar Bindhani
BDBhagirathi Dwibedi
Bhagirathi Dwibedi
Dengue is a highly prevalent mosquito-borne disease that is endemic in over 100 countries. It has a wider impact in terms of severity of illness and mortality risk in the absence of an effective vaccine as yet. The purpose of this study was to use meta-analysis to find out how common the dengue virus (DENV) is in India based on public data and to figure out how much of a problem. We searched, read, and reviewed about DENV in India that were available online. Forty-four cross-sectional studies were selected from the 178 records. There were reports of dengue cases in 14 out of the 28 states. Out of the patients presenting with symptoms of Dengue 27% of people were confirmed to have DENV infection with 82.29% (95% CI. 81-84%), having dengue IgM, 41.67% (95% CI: 40.16-43.43), having dengue IgG, and 23.97% (95% C.I. 14-43%), having both IgG and IgM from positive sample n=27156. Hospital-based cross-sectional studies on suspected Dengue-like illness (DLI) found that 99.48% of people had confirmed dengue out of the patients with features of DLI, and community-based studies found that 0.52% of DLI cases had dengue. The seroprevalence rates for East, South, North, and Western regions were 35.38% (95% C.I.14-31%), 11.57% (95% C.I. 2-69%), 38.10% (95% C.I. 9-61%), and 14.87% (95% C.I. 6-38%) correspondingly. DENV is interestingly spreading across the whole country, and the disease’s frequency varies a lot from place to place and from 2010-2023. However this review does not find appropriate published literature from 50% of the Indian states. The identification of IgG-class antibodies to dengue virus is indicative of prior exposure to this pathogen. Almost all immunocompetent individuals should have developed IgG antibodies against the dengue virus within three weeks of exposure. The presence of dengue virus IgM-class antibodies is indicative of an acute phase of infection. National Vector borne Disease Control Programme (NVBDCP) has some surveillance information, appropriate designed research into prevalence and risk factors for DENV infection would be required to provide adequate information for public health intervention.

1 August 2023 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
MMMonalisa Mohanty
Monalisa Mohanty
BMBaijayantimala Mishra
Baijayantimala Mishra
ASAmit Kumar Satapathy
Amit Kumar Satapathy
KGKrishna Mohan Gulla
Krishna Mohan Gulla
RDRashmi Ranjan Das
Rashmi Ranjan Das
SPSailendra Panda
Sailendra Panda

15 May 2024 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
PMPrabhudutta Mamidi
Prabhudutta Mamidi
SPSailendra Panda
Sailendra Panda
ARAmrita Ray
Amrita Ray
MMMonalisa Mohanty
Monalisa Mohanty
MMMadhab Charan Mandal
Madhab Charan Mandal
BMBaijayantimala Mishra
Baijayantimala Mishra

15 April 2025 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
DMDiksha Mohapatra
Diksha Mohapatra
BMBaijayantimala Mishra
Baijayantimala Mishra
PMPrabhudutta Mamidi
Prabhudutta Mamidi
SPSailendra Panda
Sailendra Panda